Cryptocurrencies
J&J’s biotech progress could punish its 2027 profit
Johnson & Johnson (JNJ) just issued one of the weirdest profit warnings in health care. The biotech business decreased its 2026 adjusted earnings guidance to between $10.96 and $11.11 a share, from a range of Read more…